Tumgik
#Tilray Brands
Text
President Joe Biden on Thursday pardoned thousands of individuals convicted of possessing marijuana, saying the current system "makes no sense" and sending pot stocks soaring on the news.
The pardons apply only to federal offenders convicted of "simple marijuana possession" as well as those charged in the District of Columbia, but Biden called on Governors across the country to follow suit.
"Just as no one should be in a federal prison solely due to the possession of marijuana, no one should be in a local jail or state prison for that reason, either," Biden said in a statement.
More than 6,500 individuals with prior convictions for simple marijuana possession were impacted by the pardons, a White House official said, and thousands more through pardons under D.C. law. The pardons will not be extended to those who weren't U.S. citizens and were illegally in the country at the time of their arrest.
Cannabis companies Tilray Brands and Canopy Growth both spiked on the news, gaining 30% and 22%, respectively, in afternoon trading. As of Thursday's close, however, each stock still traded for less than $4 per share.
In addition to the pardons, Biden announced that he has instructed Secretary of Health and Human Services Xavier Becerra and Attorney General Merrick Garland to begin reviewing how marijuana is classified under federal drug laws.
Biden noted that marijuana is currently a schedule one substance under federal drug sentencing guidelines, "the same as heroin and LSD – and more serious than fentanyl," he said. "It makes no sense."
The Justice Department's Office of the Pardon Attorney will take the lead on administering Biden's proclamation, an agency spokeswoman said.
In the coming days, the office will implement a formal process to provide pardoned individuals with a certificate of pardon, she added.
The proclamation also formally restored to these individuals all the political, civil, and other rights that were denied to them as felons.
"There are thousands of people who were convicted for marijuana possession who may be denied employment, housing, or educational opportunities as a result," Biden said. "My pardon will remove this burden on them."
The relatively small number of people who were actually pardoned on Thursday obscures the massive role that marijuana plays in the American criminal justice system.
Every year, arrests for marijuana possession typically account for between 40% to 50% of all drug arrests nationwide.
According to research compiled by the American Civil Liberties Union, between 2010 and 2018, there were 6.1 million arrests in the United States for marijuana possession. In 2018 alone, police made more arrests for marijuana, "than for all violent crimes combined."
The ACLU data also shows that these arrests disproportionately impacted people of color and low-income communities, serving to deepen existing structural inequalities.
"Too many lives have been upended because of our failed approach to marijuana," Biden said. "It's time that we right these wrongs."
Beyond Washington, Thursday's news represents a major victory for the country's nascent marijuana industry, which has struggled to gain access to major financial markets due to disparities within the patchwork of state laws that govern marijuana possession.
"Today represents action from the Administration that we have been waiting for – an acknowledgement that cannabis prohibition has failed and that too many lives have been significantly impacted as a result," said David Culver, vice president of government relations for Canopy Growth.
Biden's proclamation "has set into motion the actions needed to heal the harms of the past and chart a course for responsible, legal cannabis markets in the future," he said.
30 notes · View notes
creativitytoexplore · 2 years
Text
Stock futures fall slightly ahead of September's jobs report
Stock futures fall slightly ahead of September’s jobs report
Stock futures fell slightly on Friday morning as investors looked ahead to September’s jobs report for further clues into the Federal Reserve’s tightening campaign. S&P 500 futures dipped 0.17%, while futures tied to the Nasdaq 100 slipped 0.30%. Dow Jones Industrial Average futures were little changed. Advanced Micro Devices’ stock fell in overnight trading after the chipmaker warned its…
Tumblr media
View On WordPress
1 note · View note
karagin22 · 9 months
Text
18 notes · View notes
brewyork · 1 year
Text
The 2023 Guide to Beer at Citi Field
Tumblr media
While the Mets are in the midst of an utterly miserable early-season slide, the situation on the field leaves about as much to be desired as the beer situation at Citi Field. While for the past several years, there were dedicated kiosks to local craft beer at the stadium, the beer selection has devolved to be a mile wide and an inch deep — more availability across the stadium, but far fewer selections, and even fewer local ones.
Citi Field’s beer selection is largely dominated by Mets major sponsor MillerCoors, with the macro beers, Blue Moon original and Moon Haze, and the Vizzy and Topo Chico-branded seltzers all regularly available throughout the stadium. Boston Beer has a dominant presence this year, with both Dogfish Head (60 Minute IPA and SeaQuench) and Coney Island (Merman IPA, Mermaid Pilsner, and Beach Beer) widely available, but seemingly the only Sam Adams-branded product on offer is their N/A IPA, Just the Haze. Montauk Brewing, which got a big boost when they were acquired by cannabis company Tilray last year, is widely available, offering the Wave Chaser IPA and Summer Ale. Brooklyn Brewery, which has been available in fits and starts at Citi Field since its inception, has Lager, Summer Ale, Pulp Art IPA, and Pilsner this season — though the Pilsner was a hard find, spotted only on draft at Pig Beach behind section 135. Sloop Juice Bomb is one of the few returning craft beers this year, and there’s one new entrant: Glen Cove-based Garvies Point Brewing, who’s got cans of their Crescent Kolsch.
The big reason for the dearth of indie craft options this year: 16-ounce cans are gone from the stadium. It appears that Aramark, Citi Field’s concessionaire, required that any local or craft beer be sold in a 19.2-ounce can. Putting aside that 19.2 ounces is more IPA than I really want to drink, it’s an unreasonable ask for small breweries that would not typically have both the supply of cans and capability to can in that format. In past years, the Empire State Craft stands would exclusively offer 16-ounce cans at a fixed price point. And despite the average length of games being notably shorter this year, the beers are now sold to last longer (and, on hot days, probably get warm before you can finish them).
As far as pricing goes, not too much has changed. While the $14.25 16-ounce craft cans are gone, the handful of 19.2-ounce cans last season from Dogfish Head and Brooklyn were priced at $15.25 — the same price as this year. 24-ounce macro beers are still $15.50, and 24-ounce cans of Blue Moon and Leinenkugel Summer Shandy will continue to set you back $16.50.
Anyway, if you’re looking for the best beer selection on each level, here’s a quick and easy guide:
Field Level: Montauk Brewing stand behind section 128
Excelsior Level: the beer stand behind sections 301/302 on the Coca-Cola Porch
Promenade Level: the beer stand behind section 418 (where the Empire State Craft stand was in past seasons)
One notable omission from the beer list this year: EBBS Brewing Co., beer that’s quite literally brewed under Citi Field’s right field stands. Of course, you can still have their more reasonably-priced beers before and after the game at their taproom.
10 notes · View notes
magicnugalmanac · 9 hours
Text
Tumblr media
Germany recently legalized marijuana for personal use, opening up a significant opportunity for cannabis companies. Three weed stocks are poised to benefit the most from this new legislation: Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB).
Tilray Brands (TLRY) is a leading cannabis stock in Germany, with a strong presence in the country since 2016. It currently dominates the medical marijuana market and has a distribution arm, CC Pharma, that can supply medical marijuana to 13,000 pharmacies in Germany. With production facilities in Portugal and Canada, Tilray is well-positioned to capitalize on the growing market.
Canopy Growth (CGC) has also been operating in Germany for years and supplies the medical marijuana market. The company acquired Storz & Bickel, a global leader in vaporizers, in 2018, further diversifying its offerings. Canopy Growth has a manufacturing facility in Tuttlingen, Germany, and has seen steady growth in revenue from its vaporizer products.
Aurora Cannabis (ACB) is one of the three companies with marijuana cultivation permission in Germany. The company owns state-of-the-art production facilities in Germany that have received GMP certifications. Aurora produces high-quality medical marijuana and has a strong presence across Europe.
While these three cannabis stocks are well-positioned to benefit from Germany’s legalization of marijuana, investors should exercise caution. The Canadian experience with marijuana legalization showed the challenges that can arise from government regulation. However, with their strong foothold in the German market and beyond, Tilray Brands, Canopy Growth, and Aurora Cannabis are primed to see significant growth in the coming years.
🌿 Dive into the world of cannabis with us! Explore a wide array of products for every stage of your journey, from seeds to grow your plants, to essentials for cultivation and distribution. Whether you're nurturing your first plant or managing a full-scale operation, find all your cannabis needs here. Stay supplied with us! 🌱😗💨
0 notes
earningswhisper · 17 days
Text
Despite the boost in revenue Profitability not Reached by at the TLRY over the most recent fiscal period
Despite the positive surge in revenue reported by Tilray Brands Inc in the third quarter of 2023, there are alarming red flags that suggest a bearish outlook for the company. First and foremost, the fact that Tilray reported a loss of $-0.12 per share is concerning. This indicates that the company is not profitable and is unable to generate earnings for its shareholders. The growing shortfall from the previous year, coupled with a decrease in revenue, paints a bleak picture of Tilray?s financial performance. Addition
0 notes
fmarkets · 4 months
Text
Tumblr media
Tilray Brands Inc Delivers Exceptional Performance in Fiscal Q2 2023 Tilray Brands Inc's Financial Results Showcase Strong Growth and Promising Prospects https://csimarket.com/stocks/news.php?code=TLRY&date=2024-01-10153514&utm_source=dlvr.it&utm_medium=tumblr
0 notes
rodjbeerventures · 5 months
Text
The next frontier 🤔 https://www.just-drinks.com/interviews/tilray-brands-ceo-irwin-simon-beer/
0 notes
craffbeertimes · 5 months
Link
Tilray Brands’ Expansion in Craft Beer #craftbeer #beer
0 notes
Text
Maximize Your Trades. Trading Signals 31 October 2023 & Strategy Inside
Trading Signals 31 October 2023. Tilray Brands, Hanesbrands, Sabre Corporation, Waters Corporation, Baker Hughes #PEP #PWR #RCL #UGI #RKT #NEE #AAPL #AI #NI #ETR #SIRI #HON #SCHW #DUK #FRT #EL #MAN #LKQ #SABR #HBI #TLRY #WAT #BKR #LIN #CAG #INGR #MCD #CPB
Trading Signals 31 October 2023. Texas Instruments Incorporated, Apple, Unity Software, Pepsico, Rocket Companies, UGI Corporation, Starbucks, NextEra Energy, Quanta Services, C3 AI, NiSource, Entergy Corporation, Sirius XM Holdings, Honeywell International, Charles Schwab Corporation, Duke Energy Corporation, Federal Realty, Estee Lauder Companies, ManpowerGroup, Tilray Brands, Hanesbrands,…
Tumblr media
View On WordPress
0 notes
mi-researchreports · 7 months
Text
The Medical Marijuana Market is growing at a CAGR of 17.79% over the next 5 years. Aurora Cannabis, Jazz Pharmaceuticals, Inc., Canopy Growth Corporation, Acreage Holdings, Tilray Brands, Inc. are the major companies operating in Medical Marijuana Market.
0 notes
ailtrahq · 8 months
Text
TLRY stock price is in a bullish momentum; making a higher high structure. Currently, the Tilray stock price is trading above the key moving averages and the 50 EMA crossed the 100 EMA in an upward direction showing bulls’ presence in the stock. Moreover, big buying activity is seen in stock as the green volume candles increase on the chart and the price surges beyond 200 EMA. It showcases the presence of buyers in the stock.  TLRY stock price is currently trading at $2.91 with a massive drop of -12.08% in the last intraday session. Tilray Brands has a market cap of $2.046 Billion and floating shares of 693.406 Million. However, the company doesn’t pay any dividends as of now. In the last 6 months, the company’s performance was good. Tilray stock gave a return of 22.78% in six months and a return of 69.19% in the last three months. Last month, it gave a return of 13.23%. However, the stock displayed some weakness this week and went down by -3.00%. TLRY Stock: Tilray Stock Price Roadmap to $5 Tilray’s stock price currently trading above the key moving averages of 50, 100, and 200. However, the stock is trying to sustain above the 200 moving average. The 50 EMA line gives a bullish crossover with 100 EMA  and heading towards 200 EMA. Moreover, the scenario indicates bullish sentiments about the stock. RSI is currently trading above the median line near the overbought territory. The RSI line takes a sudden reversal from the overbought zone after the unusual drop in stock price. Currently, the RSI is trading at 56.75 and the 14 SMA line is at 60.75 showcasing neutrality. At press time the MACD curve is floating in the positive territory beyond the zero line. MACD line is at 0.2067 above the signal line 0.1814 indicating bullishness on the chart.  Overall, the indicators support the TLRY stock price and showcase bullishness on the chart and the price action also suggests an uptrend in the upcoming days. Analysts Take on TLRY Stock Price There is a mixed opinion among 18 analysts who follow Tilray stock. Almost 5 of them rate the stock as a “Strong Buy”, while 0 give it a “Buy” rating.  About 13 analysts recommend holding the stock and none of them advise selling it. The overall weightage is on the buying side. Source: Tradingview Tilray stock has an average price target of $2.68 which implies a decline of 8.08% from its current price of $2.91. The price targets vary from a high of $4.25 to a low of $1.90. Summary TLRY stock price is in a bullish momentum by making higher high structure and heading upward. RSI, MACD, and EMAs are giving bullish signals. Overall, the scenario is indicating a bullish signal and it seems that the stock will reach the $5 mark in the upcoming sessions. Technical Levels Support Levels: S1 $2.38, and S2 $1.79. Resistance Levels: R1 $3.33, and R2 $3.69. This article is for informational purposes only and does not provide any financial, investment, or other advice. The author or any people mentioned in this article are not responsible for any financial loss that may occur from investing in or trading. Please do your own research before making any financial decisions Source
0 notes
brewyork · 9 months
Text
A-B to sell off Blue Point to owner of Montauk Brewing Co.
Tumblr media
A blockbuster deal in beer this week that involves Anheuser-Busch selling off some of its craft beer assets will have local implications here in New York. Blue Point Brewing in Patchogue is among eight brands that A-B will sell to Tilray Brands, a Canadian cannabis company that has been growing its craft beverage portfolio since first acquiring Georgia-based SweetWater Brewery in 2020. Tilray more recently acquired Montauk Brewing Co. late last year.
A-B is selling eight brands in full: Blue Point, 10 Barrel, Red Hook, Widmer, Breckenridge, and Shock Top in the beer space, plus Square Mile Cider and HiBall Energy. The all-cash deal is expected to close at the end of the year, and indications are that the brands sold for an estimated $85 million.
In New York, the deal essentially merges Long Island’s two biggest beer brands. The transaction will include Blue Point’s production space and taproom in Patchogue, opening up the opportunity for consolidating production of Montauk’s core brands in-house (most are currently contract brewed). There are other regional synergies in the broader deal, with four Pacific Northwest brands all coming into Tilray’s portfolio, and the acquisition of Breckenridge Brewery aligning with the company’s existing ownership of Breckenridge Distilling.
Tilray has been investing heavily in Montauk this year following acquiring the brand, expanding their distribution footprint across several markets, including Upstate New York and most recently eastern Pennsylvania last week. Time will tell if similar investments will be made in Blue Point, or any of the newly-acquired brands.
2 notes · View notes
mikunziv · 8 months
Text
Tilray Brands takes full ownership of cannabis drinks maker Truss Beverage | Nasdaq
Tilray Brands said on Friday it had acquired the remaining 57.5% stake it did not own in cannabis-infused drinks maker Truss Beverage from Molson ...
0 notes
jaxbeerguy · 9 months
Text
Anheuser-Busch to Shed Eight Craft Brands
In a strategic maneuver that sent ripples through the beverage industry, Anheuser-Busch, the iconic beer giant, made waves with its decision to sell a portfolio of brands to Tilray, a prominent player in the cannabis market. Tilray will acquire Shock Top, Breckenridge Brewery, Blue Point Brewing Company, 10 Barrel Brewing Company, Redhook Brewery, Widmer Brothers Brewing, Square Mile Cider…
Tumblr media
View On WordPress
0 notes
fmarkets · 7 months
Text
Tumblr media
Massive Surge in Revenue Propels Tilray Brands Inc to New Heights in Q1 2024 $TLRY #Nasdaq
0 notes